Tacrolimus (FK506) treatment of CD34+ hematopoietic progenitor cells promote the development of dendritic cells that drive CD4+ T cells toward Th2 responses

Journal of Leukocyte Biology

Volumn 68, Issue 5, 2000, Pages 633-640

  Shimizu, K ^a   Fujii, S I ^a   Fujimoto, K ^a   Kawa, K ^a   Yamada, A ^a   Kawano, F ^a  

^a ROCKEFELLER UNIVERSITY   (United States)

Author keywords

Dendritic cell; Hematopoietic progenitor cell; Tacrolimus (FK506); Th2

Indexed keywords

CD1 ANTIGEN; CD34 ANTIGEN; CD4 ANTIGEN; GAMMA INTERFERON; INTERLEUKIN 12; INTERLEUKIN 4; KEYHOLE LIMPET HEMOCYANIN; TACROLIMUS;

ALLOGENEIC RESTRICTION; ARTICLE; BONE MARROW TRANSPLANTATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; DENDRITIC CELL; GRAFT VERSUS HOST REACTION; HEMATOPOIETIC STEM CELL; HUMAN; HUMAN CELL; NORMAL HUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; T LYMPHOCYTE; TH2 CELL;

ANTIGENS, CD34; CD4-POSITIVE T-LYMPHOCYTES; CELL DIFFERENTIATION; CLONE CELLS; DENDRITIC CELLS; HEMATOPOIETIC STEM CELLS; HUMANS; IMMUNOPHENOTYPING; IMMUNOSUPPRESSIVE AGENTS; INTERLEUKIN-10; INTERLEUKIN-12; LYMPHOCYTE ACTIVATION; LYMPHOCYTE CULTURE TEST, MIXED; PHAGOCYTOSIS; TACROLIMUS; TH1 CELLS; TH2 CELLS;

EID: 0033766363     PISSN: 07415400     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (40)

1. Dendritic cells and the control of immunity
2. Activated dendritic cells from bone marrow cells of mice receiving cytokine-expressing tumor cells are associated with the enhanced survival of mice bearing syngeneic tumors
3. + T cells
4. Interleukin-12 is produced by dendritic cells and mediates T helper 1 development as well as interferon-γ production by T helper 1 cells
5. Reciprocal expression of interferon gamma or interleukin 4 during the resolution or progression of murine leishmaniasis Evidence for expansion of distinct helper T cell subsets
6. Differing lymphokine profile of functional subsets of human CD4 and CD8 T cell clones
7. Human dendritic cells require exogenous interleukin-12-inducing factors to direct the development of naive T-helper cells toward the Th1 pheno-type
8. + T cells in the pathogenesis of organ-specific autoimmune diseases
9. The immunopatho-physiology of acute graft-versus-host-disease
10. Recent advances in graft-versus-host disease (GVHD)
11. Tacrolimus: A new agent for the prevention of graft-versus-host disease in hematopoietic stem cell transplantation
12. Quantitative analysis of T helper 1, T helper 2, and inflammatory cytokine expression in patients after allogeneic bone marrow transplantation: Relationship with the occurrence of acute graft-versus-host disease
13. Split activity of interleukin-10 on antigen capture and antigen presentation by human dendritic cells: Definition of a maturative step
14. IL-10 prevents the differentiation of monocytes to dendritic cells but promotes their maturation to macrophages
15. Interleukin-10 prevents the generation of dendritic cells from human peripheral blood mononuclear cells cultured with interleukin-4 and granulocyte/macrophage-colony-stimulating factor
16. Induction of tolerance by IL-10-treated dendritic cells
17. 2 promote type 2 cytokine production in maturing human naive T helper cells
18. Glucocorticoids affect human dendritic cell differentiation and maturation
19. Corticosteroids inhibit the production of inflammatory mediators in immature monocyte-derived DC and induce the development of tolerogenic DC3
20. Cyclosporine A inhibits the expression of costimulatory molecules on in vitro-generated dendritic cells
21. Mode of action of tacrolimus (FK506): Molecular and cellular mechanism
22. Striking augmentation of hematopoietic cell chimerism in noncytoablated allogeneic bone marrow recipients by flt3 ligand and tacrolimus
23. Flt-3 ligand increases microchimerism but can prevent the therapeutic effect of donor bone marrow in transiently immunosuppressed cardiac allograft recipients
24. Topical FK506 suppresses cytokine and costimulatory molecule expression and local draining lymph node cells during primary skin immune responses
25. + cord blood cell-derived and irradiated tumor cell-primed dendritic cells
26. + hematopoietic progenitor cells: Induction of autologous cytotoxic T lymphocytes against leukemic cells in acute myelogenous leukemia patients
27. + cells
28. Identification of hematopoietic progenitors of macrophages and dendritic Langerhans cells (DL-CFU) in human bone marrow and peripheral blood
29. + bone marrow progenitors that are expanded by c-kit-ligand and yield pure dentritic cell colonies in the presence of granulocyte/macrophage colony-stimulating factor and tumor necrosis factor-alpha
30. Direct demonstration of cytokine synthesis heterogeneity among human memory/effector T cells by flow cytometry
31. Effect of an immunosuppressant, FK506, on interleukin 1α production by human macrophages and a macrophage-like cell line, U937
32. FK-506, a novel immunosuppressant isolated from a Streptomyces. I. Fermentation, isolation, and physico-chemical and biological characteristics
33. Evaluation of a novel 'intelligent' dosing system for optimizing FK 506 therapy
34. Effects of immunosuppressants, FK506, deoxyspergualin, and cyclosporine A on immature human hematopoiesis
35. + hemtopoietic progenitors from human cord blood differentiated along two independent dendritic cell pathway in reponse to GM-CSF + TNF-α
36. Dysregulation of cytokines during graft-versus-host disease
37. Transplantation of polarized type 2 donor T cells reduces mortality caused by experimental graft-versus-host disease
38. Effects of exogeneous interleukin 10 in a murine model of graft-versus-host disease to minor histocompatibility antigens
39. In vivo administration of granulocyte colony-stimulating (G-CSF), granulocyte-macrophage CSF, interleukin 1 (IL-I), and IL-4, alone and in combination, after allogeneic murine hematopoietic stem cell transplantation
40. Dendritic cell tolerogenicity and prospects for dendritic cell based therapy of allograft rejection and autoimmunity